Sec. 18.5. Before reporting patient information to the INSPECT program, an opioid treatment program shall comply with 42 CFR 2.36 and 42 CFR 2.31 in obtaining patient consent. As added by P.L.133-2026, SEC.5.
Patient consent
Ind. Code § 25-26-24-18.5, under Central Repository for Controlled Substances Data.
Ind. Code § 25-26-24-18.5